ADDED
As of January 30, 2026, there were 695,043,997 shares of the registrant s $1.00 par value common stock outstanding.
As more fully set forth under Item 1A, Risk Factors in this report, principal risks and uncertainties that may affect our business, financial condition, or results of operations include: changes to regulatory, funding, staffing, trade, and other policies and actions by the U.S.
The information disclosed through those channels may be considered to be material, so investors should monitor them in addition to our press releases, Securities and Exchange Commission ( SEC ) filings, and public conference calls and webcasts.
We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and senior housing real estate.
Under the senior housing segment, our properties are operated through RIDEA structures.
We have other non-reportable segments that are comprised primarily of: (i) loans receivable, (ii) a preferred equity investment, and (iii) three other properties .
On March 1, 2024 (the Closing Date ), we completed our merger with Physicians Realty Trust (the Merger ).
In December 2025, we confidentially submitted a draft registration statement on Form S-11 to the SEC relating to the proposed initial public offering (the Offering or Janus Living Offering ) of shares of common stock of a newly formed company, Janus Living, Inc.
( Janus Living ), which will be dedicated to senior housing and which intends to elect and qualify to be taxed as a REIT.
We will contribute our 34-community, 10,422-unit senior housing portfolio to Janus Living in exchange for a majority ownership interest in Janus Living.
REMOVED
As of January 31, 2025, there were 699,564,637 shares of the registrant s $1.00 par value common stock outstanding.
In 2023, we completed our corporate reorganization (the Reorganization ) into an umbrella partnership REIT ( UPREIT ).
We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community ( CCRC ) real estate.
Under the CCRC segment, our properties are operated through RIDEA structures.
We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets (our SWF SH JV ) and (ii) loans receivable.
The Merger On March 1, 2024 (the Closing Date ), pursuant to the Agreement and Plan of Merger dated October 29, 2023 (the Merger Agreement ), by and among us, DOC DR Holdco, LLC, one of our wholly owned subsidiaries ( DOC DR Holdco ), DOC DR, LLC, a wholly owned subsidiary of Healthpeak OP ( DOC DR OP Sub ), Physicians Realty Trust, Physicians Realty L.P.
On the Closing Date, each outstanding common share of Physicians Realty Trust (other than Physicians Realty Trust common shares that were canceled in accordance with the Merger Agreement) were converted into the right to receive 0.674 (the Exchange Ratio ) shares of our common stock, and each outstanding common unit of the Physicians Partnership was converted into common units in the successor entity to the Physicians Partnership equal to the Exchange Ratio.
At December 31, 2024, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 697 properties: (i) Outpatient medical 524 properties; (ii) Lab 139 properties; (iii) CCRC 15 properties; and (iv) Other non-reportable 19 properties.
The following table summarizes information for our reportable segments for the year ended December 31, 2024 (dollars in thousands): Segment Adjusted NOI by Reportable Segment (1) Outpatient medical $ 748,730 Lab 590,606 CCRC 136,104 _______________________________________ (1) Our Adjusted NOI for our reportable segments, which we also refer to as Total Portfolio Adjusted NOI for our reportable segments, includes results of operations from disposed properties through the disposition date.
For a description of our significant activities during 2024, see Item 7, Management s Discussion and Analysis of Financial Condition and Results of Operations Company Highlights in this report.